Doxapram
Respiratory Stimulants
- Drug class
- Respiratory Stimulants
- Availability
- See label
- Markets covered
- 1
- Products on record
- 4
Overview
Doxapram is an active pharmaceutical ingredient in the Respiratory Stimulants group (R07AB). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 4 | April 10, 2026 |
GBUnited Kingdom· MHRA
4 products
Uses
Doxapram acts as a ventilatory stimulant and is specifically indicated in the following situations: Acute Respiratory failure: 1. To stimulate ventilation in patients whose blood gas status or clinical condition suggests that severe carbon dioxide retention would occur during controlled oxygen therapy.
2. To stimulate ventilation in patients showing a progressive increase in PCO2 with mental status changes during or after controlled oxygen therapy. Following anaesthesia 1. To stimulate ventilation in the post-operative period as an aid to the reduction of post-operative pulmonary complications 2.
To permit use of effective doses of narcotic analgesics without associated problems of ventilatory depression.
How to take
Drug interactions
Known interactions involving Doxapram. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL127620623 · revised April 10, 2026
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.